Variables | Control group (n = 233) | IAH group (n = 55) | P-value |
---|---|---|---|
Age, years Male sex, % Diabetes duration, years BMI, kg/m2 HbA1c, % | 49.9 (14.5) 36.5 17.6 (11.0) 23.4 (3.5) 7.7 (0.9) | 52.8 (15.1) 36.4 17.6 (11.8) 22.9 (4.4) 7.5 (1.0) | 0.179 > 0.999 0.998 0.355 0.130 |
Diabetic complication | Â | Â | Â |
Retinopathy, % | Â | Â | Â |
NDR/SDR/PPDR/PDR Photocoagulation Nephropathy, % | 75.0/16.1/4.9/4.0 10.3 | 79.6/12.2/2.0/6.1 12.7 | 0.681 0.629 |
1st/2nd/3rd/4th/5th stage | 81.0/13.4/3.4/0.4/1.7 | 85.2/14.8/0/0/0 | 0.673 |
Peripheral neuropathy, % Severe hypoglycemia, % | 12.0 3.4 | 26.5 30.9 | 0.014* < 0.001* |
Treatment | Â | Â | Â |
CSII, % CGM usage, % isCGM, % rtCGM, % TDD/BW, U/kg Antihypertensive drug, % Cholesterol-lowering drug, % Mecobalamin, % | 39.5 56.2 32.2 24.0 0.6 (0.2) 23.2 26.6 2.6 | 23.6 56.4 36.4 20.0 0.6 (0.2) 20.0 25.5 9.1 | 0.030* > 0.999 0.633 0.597 0.090 0.721 > 0.999 0.039* |
ECG | Â | Â | Â |
QTc (Bazett’s formula), ms > 440 ms, % CV-RR, % < 3%, % | 416.4 (27.8) 14.3 3.5 (1.7) 48.6 | 414.2 (23.1) 14.3 3.1 (1.4) 50.0 | 0.697 > 0.999 0.344 > 0.999 |